These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28349829)

  • 1. MiR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1.
    Ge X; Gong L
    Tumour Biol; 2017 Mar; 39(3):1010428317695947. PubMed ID: 28349829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
    Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
    Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma.
    Wang XP; Yao J; Guan J; Zhou ZQ; Zhang ZY; Yang J
    Biomed Pharmacother; 2018 Mar; 99():817-824. PubMed ID: 29710480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-24-3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M.
    Dong X; Ding W; Ye J; Yan D; Xue F; Xu L; Yin J; Guo W
    Cell Biochem Funct; 2016 Oct; 34(7):491-496. PubMed ID: 27650047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide-induced upregulation of miR-1294 suppresses tumor growth in hepatocellular carcinoma by targeting TEAD1 and PIM1.
    Cai X; Yu L; Chen Z; Ye F; Ren Z; Jin P
    Cancer Biomark; 2020; 28(2):221-230. PubMed ID: 32280078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.
    Song J; Wang Q; Luo Y; Yuan P; Tang C; Hui Y; Wang Z
    Int J Clin Exp Pathol; 2015; 8(10):12728-37. PubMed ID: 26722462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET.
    Jiang W; Wen D; Gong L; Wang Y; Liu Z; Yin F
    Biochem Biophys Res Commun; 2018 Jun; 500(2):211-216. PubMed ID: 29627570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tumor suppressor microRNAs target glypican-3 in human liver cancer.
    Cartier F; Indersie E; Lesjean S; Charpentier J; Hooks KB; Ghousein A; Desplat A; Dugot-Senant N; Trézéguet V; Sagliocco F; Hagedorn M; Grosset CF
    Oncotarget; 2017 Jun; 8(25):41211-41226. PubMed ID: 28476031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor suppressor role of miR-4782-3p in hepatocellular carcinoma.
    Bo W; Hu Y; Feng X; Zhang H; Tian L; Liu A
    Oncol Rep; 2016 Apr; 35(4):2107-12. PubMed ID: 26782643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4.
    Hu J; Ruan J; Liu X; Xiao C; Xiong J
    Pathol Res Pract; 2018 Dec; 214(12):2039-2045. PubMed ID: 30322806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.
    Huang CY; Huang XP; Zhu JY; Chen ZG; Li XJ; Zhang XH; Huang S; He JB; Lian F; Zhao YN; Wu GB
    Oncol Rep; 2015 Jun; 33(6):2889-98. PubMed ID: 25962360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-542-3p inhibits the growth of hepatocellular carcinoma cells by targeting FZD7/Wnt signaling pathway.
    Wu W; Dang S; Feng Q; Liang J; Wang Y; Fan N
    Biochem Biophys Res Commun; 2017 Jan; 482(1):100-105. PubMed ID: 27815069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of miR-362-3p Modulates Proliferation and Anchorage-Independent Growth by Directly Targeting Tob2 in Hepatocellular Carcinoma.
    Shen H; Li W; Tian Y; Xu P; Wang H; Zhang J; Li Y
    J Cell Biochem; 2015 Aug; 116(8):1563-73. PubMed ID: 25649327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
    Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
    Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA colon cancer-associated transcript 1 functions as a competing endogenous RNA to regulate cyclin-dependent kinase 1 expression by sponging miR-490-3p in hepatocellular carcinoma progression.
    Dou C; Sun L; Jin X; Han M; Zhang B; Li T
    Tumour Biol; 2017 Apr; 39(4):1010428317697572. PubMed ID: 28381168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-Regulation of MiR-193a-3p Dictates Deterioration of HCC: A Clinical Real-Time qRT-PCR Study.
    Liu Y; Ren F; Luo Y; Rong M; Chen G; Dang Y
    Med Sci Monit; 2015 Aug; 21():2352-60. PubMed ID: 26263159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.
    Zhou Y; Huang T; Zhang J; Wong CC; Zhang B; Dong Y; Wu F; Tong JHM; Wu WKK; Cheng ASL; Yu J; Kang W; To KF
    Oncogene; 2017 Nov; 36(47):6518-6530. PubMed ID: 28759040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.